Sangeeta Talwar, one of India's first women bosses, tells women how they can succeed in the cut-throat word of business.
The benchmark BSE Sensex reclaimed the 28,000 mark, spurting by 409 points or 1.4% at 28,114 and Nifty settled above the 8,500 mark at 8,532, gains of 111 points.
The latest price revision includes mostly cardiovascular drugs, anti-bacterials, anti-herpes, contraceptives and gastrointestinal medicines
.jpg)
High retail inflation is exerting pressure on households to cut expenses wherever possible.
Growth in cities has lagged villages as consumers troubled by persistently high inflation have cut spending in the past two years.
Auto stocks are weighing on the indices.
Investor lobbies and tax lawyers estimate the bill for international funds and banks could be as high as $8 billion
'Younger people are taking steps to prevent lifestyle diseases.'
'It is fascinating to partner with consumers on the journey of self-discovery and to help shape people's preferences -- that is what I find most exciting,' Nandini Piramal tells Abhineet Kumar and Aneesh Phadnis.
The Sensex ended above 27,000 for the first time while the Nifty topped 8,100.
The company will use the proceeds to part-repay its debt, which stands at Rs 34,000 crore (Rs 340 billion) even after the recent qualified institutional placement of its shares. An RCom board committee recently approved the sale of these assets.
Anglo-Dutch parent's stake in Indian subsidiary rises from 52.5% to 67.3%.
The National Pharmaceutical Pricing Authority will soon notify prices of as many as 150 packs of essential medicines in line with the new pharma pricing policy, according to official sources.
Vinita Bali to lead global ops, new business growth; COO Berry to head India operations.
Markets rebound with financials leading the gains on hopes of a peaceful solution to the turmoil in Ukraine
Move could be aimed at integrating operations with Indian subsidiary.
The 30-share Sensex is up 253 points at 29,263 and the 50-share Nifty has gained 68 points at 8,829.
The usage of PET bottles by a handful of wine makers is set to take the drink to the masses, thanks to a packaging solution offered by Manjushree Technopack Ltd, a Bengaluru-based manufacturer of PET bottles and performs.
A probe finds several pharma majors in breach of the law; and in turn they blame the government.
Tendering the shares in an open offer will lead to higher taxation.
The oralcare major has kept its ears firmly to the ground, pushing products into the hinterland and is holding fort in urban India with innovation for continued volume growth.
The new tax regime proposed by the Modi government may not have acceptance from all corners.
Indian business, on quite a different trajectory from its global counterpart, remains relatively insulated from any kind of backlash.
On Tuesday, Novartis agreed to buy GSK's oncology products business for $14.5 billion, while selling its vaccines business, excluding flu, to GSK for $7.1 billion.
Sun Pharmaceutical Industries will take a call on whether to shut Ranbaxy's troubled factories or make changes in the top management of the latter only after its $4-billion acquisition deal is complete.
Sensex rises, Nifty ends at record high; RIL shares rally.
A glance back at some of the important ups and down Indian Inc faced in 2018.
The biotech company's revenues had fallen to as low as Rs 50 cr.
Scholarships, sports and spirit define Phee Teik Yeoh, the new CEO of Vistara in India
Ranbaxy did its maiden public issue in 1973.
If you are not happy with the price offered at buybacks, you could be in for a long haul.
Some big ones hoard cash unduly and others borrow to keep up payments to shareholders
Yoga, wellness, meditation, Ayurveda, software and ... toothpaste - Sri Sri Ravi Shankar has successfully merged business with spirituality
India Inc has few leaders who are likely to grab headlines in 2015.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances